title: Pro12Ala polymorphism of the PPAR-γ2 gene, metabolic syndrome and response to metformin in clozapine-treated patients.
authors.forename: Erika
authors.initials: E
authors.lastname: Fernández
authors.forename: Edgardo
authors.initials: E
authors.lastname: Carrizo
authors.forename: Lisette
authors.initials: L
authors.lastname: Connell
authors.forename: Trino
authors.initials: T
authors.lastname: Baptista
mesh_terms: D000328:Adult; D000368:Aged; D000409:Alanine / Q000235:genetics*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001786:Blood Glucose; D003024:Clozapine / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin; D020738:Leptin; D008297:Male; D008659:Metabolic Diseases / Q000188:drug therapy* / Q000235:genetics*; D008687:Metformin / Q000627:therapeutic use*; D008875:Middle Aged; D047495:PPAR gamma / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000235:genetics*; D011392:Proline / Q000235:genetics*
chemical_list: D014150:Antipsychotic Agents; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D020738:Leptin; D047495:PPAR gamma; D008687:Metformin; D011392:Proline; D003024:Clozapine; D000409:Alanine